🎁  Special Promo: 15% off for new account creator CREATE2026 ✦  Meet us at SITC2026 - Phoenix, Nov 4-8 🔬  New Product Launch: Human Primary Cells

MileCell to Exhibit at the 27th North American ISSX Meeting in San Francisco

MileCell is pleased to announce its participation in the 27th North American ISSX Meeting, taking place October 11–14, 2026, at the Hilton San Francisco Union Square. The MileCell team will be exhibiting at Booth #200 and looks forward to connecting with researchers working across drug metabolism, DMPK, toxicology, and in vitro model development.

Held under the theme “Back to the Future: DMPK Foundations and New Concepts,” this year’s meeting highlights how established experimental tools continue to support new approaches in drug discovery and development — from hepatic clearance and drug–drug interaction studies to emerging in vitro models. Choosing the right biological model, and having confidence in its quality and performance, remains an essential part of that work.

What to Explore at Booth #200

Primary Hepatocytes
Plateable and suspension hepatocytes for metabolism, clearance, induction, toxicity, and transporter studies — including lots qualified for induction, transporter applications, and 3D spheroid culture.

Liver Non-Parenchymal Cells
Kupffer cells, hepatic stellate cells, liver sinusoidal endothelial cells (LSECs), and NPC mixes for inflammation, fibrosis, toxicity, and disease modeling.

Liver and Intestinal Subcellular Fractions
Microsomes, S9 fractions, cytosol, lysosomes, tritosomes, and tissue homogenates for metabolism, DDI, and bioactivation studies.

Schedule a Meeting

Attendees are invited to stop by Booth #200 or schedule a meeting with the MileCell team in advance to discuss technical data and product information, quotations and product recommendations, evaluation sample availability, or a specific research workflow or study challenge.

To arrange a meeting, please contact sales@milecell-bio.com.

We look forward to seeing you in San Francisco!

About MileCell
MileCell provides high-quality biological products for ADMET and drug discovery research, including primary hepatocytes, liver non-parenchymal cells, and liver and intestinal subcellular fractions. Our products support researchers in metabolism, clearance, induction, toxicity, transporter, and drug–drug interaction studies, helping accelerate drug development programs worldwide.